| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88161461 | FILING DATE | 10/19/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | CRENNAN, KEVIN GERARD |
L.O. ASSIGNED | 113 |
PUB INFORMATION |
|||
| RUN DATE | 11/04/2020 | ||
| PUB DATE | 09/17/2019 | ||
| STATUS | 731-SECOND EXTENSION - GRANTED | ||
| STATUS DATE | 11/02/2020 | ||
| LITERAL MARK ELEMENT | INGREZZA | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | INGREZZA |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Neurocrine Biosciences, Inc. |
| ADDRESS | 12780 El Camino Real San Diego, CA 92130 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for human use for schizophrenia, schizoaffective disorder, bipolar disorder, bipolar mania, DiGeorge syndrome, Lesch-Nyhan syndrome, and Tourette syndrome, movement disorders, namely, Myoclonus, Huntington's chorea, Levodopa-induced dyskinesia, tardive dyskinesia, dystonia, and tics |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | Color is not claimed as a feature of the mark. |
| DESCRIPTION OF MARK | The mark consists of a sequence of right pointing arrows and the word "INGREZZA". |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 11/04/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 026 |
| 11/02/2020 | EX2G | S | EXTENSION 2 GRANTED | 025 |
| 11/02/2020 | EXT2 | S | EXTENSION 2 FILED | 024 |
| 11/02/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 023 |
| 05/13/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 022 |
| 05/11/2020 | EX1G | S | EXTENSION 1 GRANTED | 021 |
| 05/11/2020 | EXT1 | S | EXTENSION 1 FILED | 020 |
| 05/11/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 019 |
| 11/12/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 018 |
| 09/17/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 017 |
| 09/17/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 016 |
| 08/28/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 015 |
| 08/15/2019 | ALIE | A | ASSIGNED TO LIE | 014 |
| 08/07/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 013 |
| 07/31/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 012 |
| 07/30/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 011 |
| 07/30/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 010 |
| 05/17/2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 009 |
| 05/17/2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 008 |
| 01/31/2019 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | 007 |
| 01/31/2019 | GPRA | F | PRIORITY ACTION E-MAILED | 006 |
| 01/31/2019 | CPRA | R | PRIORITY ACTION WRITTEN | 005 |
| 01/24/2019 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
| 11/01/2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 003 |
| 10/31/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 10/23/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | B. Brett Heavner |
| CORRESPONDENCE ADDRESS | B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & 901 New York Avenue NW Washington DC 20001 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Neurocrine Biosciences, Inc. |
| ADDRESS | 12780 El Camino Real San Diego, CA 92130 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |